-
公开(公告)号:US20250066723A1
公开(公告)日:2025-02-27
申请号:US18843203
申请日:2023-03-02
Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. , RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Yechiel ELKABETZ , Naresh MUTUKULA , Sneha ARORA , Daniel ROSEBROCK
IPC: C12N5/079 , C12N5/0793
Abstract: The present invention relates to a method for the generation of outer radial glial (oRG) cells of the outer sub-ventricular (oSVZ)-like region in cerebral organoids comprising (a) culturing primate stem cells in a primate stem cell medium until about day 6, thereby inducing the formation of embryonic bodies; (b) culturing the embryonic bodies as obtained in step (a) in a neural induction medium until about day 11, thereby inducing the formation of organoids; wherein an inhibitor of TGF-β, an inhibitor of BMP and an inhibitor of WNT is present from about day 2 until about day 11; (c) embedding the organoids as obtained after steps (a) and (b) and if they display a size of at least 300 μm into a hydrogel that mimics the extracellular matrix (ECM), preferably Matrigel and culturing the organoids in a cerebral differentiation medium at least until about day 40, preferably at least until about day 60 and most preferably at least until about day 80, thereby obtaining cerebral organoids with oRG cells in oSVZ-like regions, wherein the organoids in step (c) are subjected to agitation from about day 15 onward, preferably by using an orbital shaker or a spinning bioreactor; and (d) optionally isolating one or more oRG cells from the oSVZ-like region.
-
公开(公告)号:US20250061999A1
公开(公告)日:2025-02-20
申请号:US18719323
申请日:2022-12-13
Inventor: Amir GLIK , Miriam FURST-YUST , Felix BENNINGER
Abstract: A system which can be used for carrying out a method for determining an efficacy of a transcranial magnetic stimulation (TMS) treatment, including: delivering TMS to a patient using a TMS protocol in a TMS treatment session; recording EEG signals before and after the delivering during the treatment session; recording EEG signals after completion of the treatment session; analyzing the recorded EEG signals to generate values of one or more EEG parameters; determining an acute effect and an intermediate effect of the TMS protocol on a brain state of the patient based on a change in values of the one or more EEG parameters; determining an efficacy of the TMS protocol based on the determined acute effect and the intermediate effect.
-
公开(公告)号:US20250052664A1
公开(公告)日:2025-02-13
申请号:US18717651
申请日:2022-12-14
Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Natan Tzvi SHAKED
Abstract: Some embodiments relate to a data analysis system is presented for inspecting unstained biological cells during fast flow. The data analysis system comprises: a data input utility, and data processor. The data input utility receives raw measured data comprising measured data pieces corresponding to a stream of raw data containing wavefront acquisitions collected from said unstained biological cell under inspection being obtained from the unstained biological cell during the fast flow. The data processor and analyzer is configured and operable to apply to said raw measured data real time processing by a trained neural network model and extract cell-related data.
-
公开(公告)号:US20250043278A1
公开(公告)日:2025-02-06
申请号:US18928324
申请日:2024-10-28
Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Tamir TULLER , Ofek SCHNITZER , Hadas ZUR , Zohar ZAFRIR
IPC: C12N15/11 , C12N9/22 , C12N15/67 , C12Q1/6886
Abstract: The present invention is directed to a method for treating cancer in a subject determined as having the presence of a G600>A substitution, a C601>T substitution, or both, in the B cell lymphoma 2 (BCL2) gene of a cell.
-
公开(公告)号:US20250043234A1
公开(公告)日:2025-02-06
申请号:US18250594
申请日:2021-10-28
Inventor: Iftach YACOBY , Tamar ELMAN , Oren BEN ZVI , Chris Philip SCHWIER , Thi Thu Hoai HO , Michael HIPPLER
Abstract: The present invention is in the field of molecular hydrogen (H2) bio-production, particularly, the present invention provides genetically modified photosynthetic microalgae producing hydrogen in complete growth medium under ambient, continuous growth conditions at cost-effective amounts and to a process for hydrogen production using genetically modified photosynthetic microalga.
-
公开(公告)号:US20250032580A1
公开(公告)日:2025-01-30
申请号:US18552263
申请日:2022-03-25
Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Illana GOZES
Abstract: Uses of ADNF polypeptides in therapy are provided. Accordingly, there is provided a method of treating a disease associated with visual evoked potential impairment and/or speech impairment that is not due to vocal disturbance and in which the subject suffers from the visual evoked potential impairment and/or speech impairment, the method comprising administering to the subject a therapeutically effective amount of an ADNF polypeptide, wherein said ADNF polypeptide has a neurotrophic/neuroprotective activity in an in vitro cortical neuron culture assay.
-
公开(公告)号:US12201452B2
公开(公告)日:2025-01-21
申请号:US16326385
申请日:2017-08-22
Applicant: Ramot at Tel-Aviv University Ltd.
Inventor: Fernando Patolsky , Vadim Krivitsky , Omri Heifler , Marina Zverzhinetsky
IPC: A61B5/00 , A61B5/145 , A61B5/1473 , A61B5/1486 , A61B5/1495 , A61M37/00
Abstract: A system for monitoring at least presence of a bioanalyte. The system comprises: a substrate having a skin contact surface, a microneedle outwardly protruding from the skin contact surface, a sensing complex positioned in the microneedle, and a circuit attached to the substrate. The sensing complex can comprise a nanostructure modified by a functional moiety covalently attached thereto, and an affinity moiety effective to react specifically with the bioanalyte to produce a reaction product. The circuit can apply voltage to the nanostructure and monitor changes in an electrical property of the nanostructure responsively to reaction between the reaction product and the functional moiety.
-
公开(公告)号:US20250018048A1
公开(公告)日:2025-01-16
申请号:US18710002
申请日:2022-11-16
Applicant: Ramot at Tel-Aviv University Ltd.
Inventor: MICHA FRIDMAN , REBECA ELIAS , PALLABITA BASU
IPC: A61K47/55 , A01N43/653 , A01P3/00 , A61P31/10
Abstract: A novel dual-acting class of antifungal compound synthesized by linking an azole pharmacophore to a COX inhibitor to form a hybrid molecule. A method of making the antifungal compound by preparing a mixture of an azide-functionalized pharmacophore, subjecting the azide-functionalized pharmacophore to catalytic hydrogenation to obtain an amine-functionalized azole pharmacophore, and coupling a COX inhibitor to the amine-functionalized azole pharmacophore. A method for treating fungal infection in plants and animals comprising administering the antifungal compound.
-
公开(公告)号:US20240425710A1
公开(公告)日:2024-12-26
申请号:US18822661
申请日:2024-09-03
Applicant: Ramot at Tel-Aviv University Ltd.
Inventor: Lihi ADLER-ABRAMOVICH , Francesca NETTI
IPC: C09D11/04 , A61L27/26 , A61L27/52 , B29C64/112 , B29K105/00 , B29L31/00 , B33Y10/00 , B33Y70/00 , B33Y80/00 , C08L89/06
Abstract: Bioink compositions comprising a plurality of aromatic peptides and a matrix-forming material, formulations and kits for preparing same, additive manufacturing (bioprinting) processes utilizing same and three-dimensional objects obtained thereby are provided.
-
公开(公告)号:US12171568B2
公开(公告)日:2024-12-24
申请号:US17435906
申请日:2020-03-03
Applicant: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED , ICHILOV TECH LTD. , RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Talma Hendler , Asya Rolls , Nitzan Lubianiker , Tamar Koren , Neomi Singer , Tamar Ben Shannan , Shai Shen Orr , Fahed Hakim , Hilla Azulay-Debby , Rani Cohen
Abstract: The present invention is directed to a method for inducing an immune response in a subject, including a step of activating neurons in the mesolimbic network of the subject by applying a neurofeedback.
-
-
-
-
-
-
-
-
-